Progress in circulating tumor cell capture and analysis: Implications for cancer management

Marija Balic, Henry Lin, Anthony Williams, Ram Datar, Richard J Cote

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The hematogenous dissemination of cancer and development of distant metastases is the cause of nearly all cancer deaths. Detection of circulating tumor cells (CTCs) as a surrogate biomarker of metastases has gained increasing interest. There is accumulating evidence on development of novel technologies for CTC detection, their prognostic relevance and their use in therapeutic response monitoring. Many clinical trials in the early and metastatic cancer setting, particularly in breast cancer, are including CTCs in their translational research programs and as secondary end points. We summarize the progress of detection methods in the context of their clinical importance and speculate on the possibilities of wider implementation of CTCs as a diagnostic oncology tool, the likelihood that CTCs will be used as a useful biomarker, especially to monitor therapeutic response, and what may be expected from the future improvements in technologies.

Original languageEnglish
Pages (from-to)303-312
Number of pages10
JournalExpert Review of Molecular Diagnostics
Volume12
Issue number3
DOIs
StatePublished - Apr 1 2012

Fingerprint

Circulating Neoplastic Cells
Neoplasms
Biomarkers
Neoplasm Metastasis
Technology
Translational Medical Research
Therapeutic Uses
Clinical Trials
Breast Neoplasms

Keywords

  • cancer stem cells
  • characterization
  • circulating tumor cells
  • CTC
  • detection
  • DTC
  • enrichment
  • epithelial-mesenchymal transition
  • metastasis

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pathology and Forensic Medicine

Cite this

Progress in circulating tumor cell capture and analysis : Implications for cancer management. / Balic, Marija; Lin, Henry; Williams, Anthony; Datar, Ram; Cote, Richard J.

In: Expert Review of Molecular Diagnostics, Vol. 12, No. 3, 01.04.2012, p. 303-312.

Research output: Contribution to journalArticle

Balic, Marija ; Lin, Henry ; Williams, Anthony ; Datar, Ram ; Cote, Richard J. / Progress in circulating tumor cell capture and analysis : Implications for cancer management. In: Expert Review of Molecular Diagnostics. 2012 ; Vol. 12, No. 3. pp. 303-312.
@article{ef6bfacd7cf04864b36afb3ecdb9f7f4,
title = "Progress in circulating tumor cell capture and analysis: Implications for cancer management",
abstract = "The hematogenous dissemination of cancer and development of distant metastases is the cause of nearly all cancer deaths. Detection of circulating tumor cells (CTCs) as a surrogate biomarker of metastases has gained increasing interest. There is accumulating evidence on development of novel technologies for CTC detection, their prognostic relevance and their use in therapeutic response monitoring. Many clinical trials in the early and metastatic cancer setting, particularly in breast cancer, are including CTCs in their translational research programs and as secondary end points. We summarize the progress of detection methods in the context of their clinical importance and speculate on the possibilities of wider implementation of CTCs as a diagnostic oncology tool, the likelihood that CTCs will be used as a useful biomarker, especially to monitor therapeutic response, and what may be expected from the future improvements in technologies.",
keywords = "cancer stem cells, characterization, circulating tumor cells, CTC, detection, DTC, enrichment, epithelial-mesenchymal transition, metastasis",
author = "Marija Balic and Henry Lin and Anthony Williams and Ram Datar and Cote, {Richard J}",
year = "2012",
month = "4",
day = "1",
doi = "10.1586/erm.12.12",
language = "English",
volume = "12",
pages = "303--312",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Progress in circulating tumor cell capture and analysis

T2 - Implications for cancer management

AU - Balic, Marija

AU - Lin, Henry

AU - Williams, Anthony

AU - Datar, Ram

AU - Cote, Richard J

PY - 2012/4/1

Y1 - 2012/4/1

N2 - The hematogenous dissemination of cancer and development of distant metastases is the cause of nearly all cancer deaths. Detection of circulating tumor cells (CTCs) as a surrogate biomarker of metastases has gained increasing interest. There is accumulating evidence on development of novel technologies for CTC detection, their prognostic relevance and their use in therapeutic response monitoring. Many clinical trials in the early and metastatic cancer setting, particularly in breast cancer, are including CTCs in their translational research programs and as secondary end points. We summarize the progress of detection methods in the context of their clinical importance and speculate on the possibilities of wider implementation of CTCs as a diagnostic oncology tool, the likelihood that CTCs will be used as a useful biomarker, especially to monitor therapeutic response, and what may be expected from the future improvements in technologies.

AB - The hematogenous dissemination of cancer and development of distant metastases is the cause of nearly all cancer deaths. Detection of circulating tumor cells (CTCs) as a surrogate biomarker of metastases has gained increasing interest. There is accumulating evidence on development of novel technologies for CTC detection, their prognostic relevance and their use in therapeutic response monitoring. Many clinical trials in the early and metastatic cancer setting, particularly in breast cancer, are including CTCs in their translational research programs and as secondary end points. We summarize the progress of detection methods in the context of their clinical importance and speculate on the possibilities of wider implementation of CTCs as a diagnostic oncology tool, the likelihood that CTCs will be used as a useful biomarker, especially to monitor therapeutic response, and what may be expected from the future improvements in technologies.

KW - cancer stem cells

KW - characterization

KW - circulating tumor cells

KW - CTC

KW - detection

KW - DTC

KW - enrichment

KW - epithelial-mesenchymal transition

KW - metastasis

UR - http://www.scopus.com/inward/record.url?scp=84859384084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859384084&partnerID=8YFLogxK

U2 - 10.1586/erm.12.12

DO - 10.1586/erm.12.12

M3 - Article

C2 - 22468820

AN - SCOPUS:84859384084

VL - 12

SP - 303

EP - 312

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 3

ER -